Patent Yard Sign in
Canadian application, no grantCanada

Dosage forms having an inner core and outer shell with different shapes

CA 2447984 A1 · Owner: Sowden, Harry S. · Inventors: Bunick, Frank J.; Mcnally, Gerard P.; Sowden, Harry S.

CIPO record

Overview

Drawings and full text

Its claims, description and drawings are in the Canadian Patents Database.

Open the CIPO record

Abstract From the Canadian patent

A dosage form comprises an active ingredient a core having an outer surface , and a first shape and a shell having outer and inner surfaces and a second shape, in which the shell surrounds at least a portion of the core and the , first and second shapes are substantially different. In one embodiment the shell comprises at least about 80% of a flowable material selected from the group consisting of film formers, gelling polymers thermoplastic materials, low melting hydrophobic materials non-crystallizable sugars, non-, crystallizable sugar-alcohols and mixtures thereof. In another embodiment the shell is substantially free of pores having a diameter of 0.5 to 5.0 microns. In another …

Read the whole patent

Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.

Why it's free to use

  • Filed September 28, 2002. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended September 28, 2022.
  • A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by September 28, 2024.
  • We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
FiledSeptember 28, 2002
GrantedNo grant recorded
Term endedSeptember 28, 2022
Patent numberCA 2447984 A1
Classification (IPC)A61K9/28 +2 more

Timeline

Timeline From CIPO dates

2003200520072009201120132015201720192021Application filedSep 28, 2002Term endedSep 28, 2022

Sources & verification

Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.